Omeros (OMER) News Today $4.19 -0.17 (-3.90%) Closing price 04:00 PM EasternExtended Trading$4.18 -0.01 (-0.12%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMER Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Omeros: Deja Vu All Over Again (Rating Downgrade)August 20 at 5:10 AM | seekingalpha.comOmeros Corporation (OMER) Q2 2025 Earnings Call TranscriptAugust 19 at 5:07 PM | seekingalpha.comOmeros Corporation (NASDAQ:OMER) Q2 2025 Earnings Call TranscriptAugust 19 at 9:30 AM | insidermonkey.comOmeros' (OMER) Buy Rating Reaffirmed at D. Boral CapitalAugust 18 at 3:49 AM | americanbankingnews.comNeedham & Company LLC Reiterates Hold Rating for Omeros (NASDAQ:OMER)August 18 at 3:49 AM | americanbankingnews.comD. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER)August 17 at 8:29 AM | marketbeat.comOmeros (NASDAQ:OMER) Given "Hold" Rating at Needham & Company LLCAugust 17 at 8:29 AM | marketbeat.comOmeros (NASDAQ:OMER) Announces Earnings Results, Misses Estimates By $0.07 EPSAugust 16, 2025 | marketbeat.comOmeros Shares Gain on Narrower 2Q LossAugust 15, 2025 | marketwatch.comOmeros Corporation Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comOmeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ...August 15, 2025 | gurufocus.comQ2 2025 Omeros Corp Earnings Call TranscriptAugust 14, 2025 | gurufocus.comOmeros reports Q2 EPS (44c), consensus (55c)August 14, 2025 | msn.comOmeros: Q2 Earnings SnapshotAugust 14, 2025 | sfgate.comOmeros Corporation Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | businesswire.comRetail investors who hold 55% of Omeros Corporation (NASDAQ:OMER) gained 12%, institutions profited as wellAugust 12, 2025 | finance.yahoo.comOmeros Corporation to Announce Second Quarter Financial Results on August 14, 2025August 11, 2025 | businesswire.comCritical Comparison: Demant A/S (OTCMKTS:WILYY) & Omeros (NASDAQ:OMER)August 11, 2025 | americanbankingnews.comOmeros Corporation (NASDAQ:OMER) Receives Consensus Rating of "Moderate Buy" from BrokeragesAugust 5, 2025 | marketbeat.comPotential Boost for Omeros (OMER) with Narsoplimab Study InsightsAugust 1, 2025 | gurufocus.comPotential Market Surge for Omeros Driven by Narsoplimab’s Edge Over EculizumabAugust 1, 2025 | tipranks.comOmeros (OMER) to Release Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comD. Boral Capital Reaffirms Buy Rating for Omeros (NASDAQ:OMER)July 26, 2025 | marketbeat.comStock Traders Buy High Volume of Call Options on Omeros (NASDAQ:OMER)July 26, 2025 | marketbeat.comFY2025 EPS Estimates for Omeros Reduced by Cantor FitzgeraldJuly 26, 2025 | marketbeat.comOmeros announces pricing of $22 million registered direct offeringJuly 25, 2025 | msn.comOMER | Omeros Corp. Annual Cash Flow Statement - MarketWatchJuly 25, 2025 | marketwatch.comOmeros Corporation Announces Pricing of $22 Million Registered Direct OfferingJuly 25, 2025 | finance.yahoo.comOmeros (OMER) Stock Rating and Price Target Maintained by D. Boral Capital | OMER Stock NewsJuly 25, 2025 | gurufocus.comOmeros Shares Rise After $22 Million Direct Offering PricesJuly 25, 2025 | marketwatch.comOmeros rises after pricing ~$22M stock offeringJuly 25, 2025 | msn.comOmeros (OMER) Announces $22 Million Stock Sale to Polar Asset ManagementJuly 25, 2025 | gurufocus.comOmeros Enters Securities Purchase Agreement with PolarJuly 25, 2025 | tipranks.comWhat is HC Wainwright's Estimate for Omeros FY2027 Earnings?July 15, 2025 | marketbeat.comOmeros Corporation (NASDAQ:OMER) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 11, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Receives Buy Rating from D. Boral CapitalJune 30, 2025 | marketbeat.comOmeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival BoostJune 30, 2025 | msn.comOmeros (NASDAQ:OMER) Downgraded to "Sell" Rating by Wall Street ZenJune 27, 2025 | marketbeat.comOmeros (OMER) Eyes European Approval for Key Drug Narsoplimab | OMER Stock NewsJune 27, 2025 | gurufocus.comOmeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMAJune 27, 2025 | businesswire.comOmeros Co. (NASDAQ:OMER) Given Consensus Rating of "Moderate Buy" by BrokeragesJune 16, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Omeros FY2025 Earnings?June 12, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Omeros (OMER) with Buy RecommendationJune 12, 2025 | msn.comOmeros Stock Short Interest Report | NASDAQ:OMER | BenzingaJune 11, 2025 | benzinga.comHC Wainwright Predicts Omeros' Q2 Earnings (NASDAQ:OMER)June 11, 2025 | marketbeat.comOmeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA DecisionJune 10, 2025 | benzinga.comBrokers Set Expectations for Omeros FY2026 EarningsJune 10, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Earns Buy Rating from Analysts at HC WainwrightJune 10, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Lowered to Sell Rating by Wall Street ZenJune 6, 2025 | marketbeat.comOmeros: On The Brink As It Awaits Its Fall PDUFA For A Potential BlockbusterMay 27, 2025 | seekingalpha.com Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address OMER Media Mentions By Week OMER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMER News Sentiment▼0.480.49▲Average Medical News Sentiment OMER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMER Articles This Week▼204▲OMER Articles Average Week Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NKTR News ASMB News CPIX News LLY News JNJ News ABBV News MRK News PFE News BMY News ZTS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMER) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omeros Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Omeros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access